Screening and use of agents which block or activate intein splicing utilizing natural or homologous exteins
AssigneeNew England Biolabs, Inc.
InventorsFrancine B. Perler, Eric E. Adam
Life of this patent
Estimating the term…
Loading patent…
AssigneeNew England Biolabs, Inc.
InventorsFrancine B. Perler, Eric E. Adam
Estimating the term…
In accordance with the present invention, there are provided selection systems and methods for screening for agents that control splicing of inteins in their native host protein (extein) or in homologous exteins. Specifically, there are provided positive genetic selection systems for the screening of agents which inhibit or activate protein splicing which comprise: a host cell containing a chromosomal gene encoding either a drug-resistant form of a target enzyme or a wild-type target enzyme, and a plasmid-borne gene encoding either a drug-sensitive form of the target enzyme, which is dominantly cytotoxic upon interaction with the drug, or a dominantly cytotoxic form of the target enzyme. In these systems the plasmid-borne gene contains an intein, and the inhibition or activation of splicing of the dominant cytotoxic form of the target enzyme by a given reagent results in the survival or death of the host cell. More specifically, positive genetic selection systems which utilize the M. xenopi GyrA intein or M. tuberculosis DnaB helicase intein are provided. Similar reporter systems utilizing native or homologous exteins and systems utilizing controllable inteins are provided, as are methods of controlling in vivo expression of proteins by modulating protein splicing with inhibiting or activating agents, and methods of controlling the delivery of proteinaceous drugs in vivo by modulating protein splicing.
A positive genetic selection system employing a precursor comprising a native intein in its natural or homologous modifiable extein context for the screening of agents which inhibit or activate protein splicing, said selection system comprising:
A method of screening for agents which inhibit protein splicing, said method comprising the steps of:
A method for screening of agents which activate protein splicing, said method comprising the steps of:
A positive genetic selection system for the screening of agents which inhibit protein splicing, said selection system comprising:
A positive genetic selection system for the screening of agents which activate protein splicing, said selection system comprising:
A reporter system for the screening of agents which inhibit protein splicing, said reporter system comprising a host cell which contains a reporter gene encoding a non-essential protein, said reporter gene containing an intein, wherein said intein is selected from the group consisting of a foreign intein inserted into the homologous or non-homologous extein of said reporter gene in the absence of a silent mutation of said extein and a natural intein in a native reporter extein, and wherein the inhibition of splicing of said non-essential protein by a given agent results in a specific detectable phenotype of said host cell.
A reporter system for the screening of agents which activate protein splicing, said reporter system comprising a host cell which contains a reporter gene encoding a non-essential protein, said reporter gene containing an inactive intein, wherein said inactive intein is selected from the group consisting of a foreign inactive intein inserted into the homologous or non-homologous extein of said reporter gene in the absence of a silent mutation of said extein and a natural inactive intein in a native reporter extein, and wherein the activation of splicing of said non-essential protein by a given agent results in a specific selectable phenotype of said host cell.
A method of controlling gene expression in vivo, said method comprising the steps of:
A method of controlling the delivery of a drug that is at least partially proteinaceous in vivo, said method comprising the steps of:
A method for generating temperature sensitive mutants of the Mxe GyrA intein in E.coli GyrA, said method comprising the steps of:
A method for generating temperature sensitive mutants of an intein, said method comprising the steps of:
A method of screening for temperature-sensitive inteins, said method comprising the steps of
A method of screening for temperature-sensitive inteins, said method comprising the steps of
A positive selection system for the screening of temperatures which inhibit protein splicing in temperature-sensitive inteins, said selection system comprising (1) a host cell which contains a first gene encoding a controllable form of a target enzyme which is required for cell viability, and (2) a second gene encoding an expressed form of said target enzyme, said second gene containing an intein, wherein said intein is mutagenized, and wherein the inhibition of splicing of said target enzyme by a given non-permissive temperature results in the reduced viability or death of said host cell under conditions which do not permit the expression of said controllable first gene of said target enzyme.
A positive selection system for the screening of temperatures which activate protein splicing in temperature-sensitive inteins, said selection system comprising (1) a host cell which contains a first gene encoding a controllable form of a target enzyme which is required for cell viability, and (2) a second gene encoding an expressed form of said target enzyme, said second gene containing an intein, wherein said intein is mutagenized, and wherein the activation of splicing of said target enzyme by a given permissive temperature results in the viability of said host cell under conditions which do not permit the expression of said controllable first gene of said target enzyme.
A reporter system for the screening of temperatures which inhibit protein splicing in temperature-sensitive inteins, said reporter system comprising a host cell which contains a reporter gene encoding a non-essential protein, said reporter gene containing an intein, wherein said intein is selected from the group consisting of a foreign intein inserted into the homologous or non-homologous extein of said reporter gene in the absence of a silent mutation of said extein and a natural intein in a native reporter extein, and wherein said intein is mutagenized, and wherein the inhibition of splicing of said non-essential protein by a non-permissive temperature results in a specific detectable phenotype.
A reporter system for the screening of temperatures which activate protein splicing in temperature-sensitive inteins, said reporter system comprising a host cell which contains a reporter gene encoding a non-essential protein, said reporter gene containing an intein, wherein said intein is selected from the group consisting of a foreign intein inserted into the homologous or non-homologous extein of said reporter gene in the absence of a silent mutation of said extein and a natural intein in a native reporter extein, and wherein said intein is mutagenized, and wherein the activation of splicing of said non-essential protein by a permissive temperature results in a specific detectable phenotype.
A positive genetic selection system for screening of agents which inhibit protein splicing, said selection system comprising:
A positive selection system for the screening of temperatures which inhibit protein splicing in temperature sensitive inteins, said selection system comprising:
A method of identifying an agent for antimicrobial activity against a microbial pathogen that naturally has an intein in an essential gene comprising screening for agents that block splicing of that intein in its native context or a homologous extein context.
A method of identifying an agent for antimicrobial activity against a microbial pathogen that naturally has an intein in an essential gene comprising screening for agents that block splicing of that intein in a heterologous extein context that includes one or more native extein residues flanking one or both ends of the intein.
A method of identifying agents with antimicrobial activity against Mycobacterium tuberculosis comprising screening for agents that inhibit splicing of the Mycobacterium tuberculosis DnaB intein.
A method of identifying agents with antimicrobial activity against Mycobacterium leprae comprising screening for agents that inhibit splicing of the Mycobacterium xenopi or Mycobacterium leprae GyrA inteins.
A method of identifying lead compounds with antimicrobial activity comprising identifying agents that inhibit splicing of an intein which is naturally present in that organism.
Dependencies are inferred from the claim text.